1:24-cv-01136 GlaxoSmithKline Biologicals SA et al v. Moderna, Inc. et al
Case Summary
GlaxoSmithKline Biologicals SA and related parties initiated litigation against Moderna, Inc. and others under docket 24-cv-01136. The case details and court jurisdiction remain unspecified, but the dispute likely involves complex issues given the parties' profiles in the pharmaceutical industry. No further procedural developments or substantive claims are provided at this time. Due to limited information, the nature of the claims, defenses, and potential outcomes cannot be fully assessed. The case remains open with no public updates on motions or rulings.
Stage
Active litigation
Timeline
2 events
Coverage
2 articles
Sources
1
Key Issues
- • Pharmaceutical patent or licensing dispute
- • Biotechnology intellectual property
- • Contractual obligations
- • Industry competition
Case Timeline
2 events1:24-cv-01136 GlaxoSmithKline Biologicals SA et al v. Moderna, Inc. et al
In the case between GlaxoSmithKline Biologicals and Moderna, an unspecified court event occurred without detailed public information. This event could involve procedural developments or administrative actions that influence the progress of the lawsuit. Understanding these events helps track the case timeline and anticipate future legal steps.
1:24-cv-01135 GlaxoSmithKline Biologicals SA et al v. Moderna, Inc. et al
In the ongoing legal dispute between GlaxoSmithKline Biologicals SA and Moderna, Inc., a new case with a similar title was filed, indicating a related or parallel proceeding. This development suggests that the parties are engaged in multiple legal actions, which could impact the overall resolution of their conflict.